Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL > Treatment > CN. B. BTK Inhibitor Capsules

---

CN. B. BTK Inhibitor Capsules's subsections
(*) AU Approval Date: 2021. 10.10
(*) BR Approval Date: ?
(*) CA Approval Date: 2021. 07.26
(*) RU Approval Date: 2021. 10.20
(*) SA Approval Date: 2021. 11.15.
Company
Generic Name: Zanubrutinib
Patent>Assignee; Claims; No.; Etc.
RTM
RTM Web-site

CN. B. BTK Inhibitor Capsules's products
This section has no products